These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19888523)

  • 21. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials.
    Mismetti P; Laporte-Simitsidis S; Tardy B; Cucherat M; Buchmüller A; Juillard-Delsart D; Decousus H
    Thromb Haemost; 2000 Jan; 83(1):14-9. PubMed ID: 10669147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Vardi M; Zittan E; Bitterman H
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006771. PubMed ID: 19821386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: An institutional experience.
    Hacker RI; Ritter G; Nelson C; Knobel D; Gupta R; Hopkins K; Marini CP; Barrera R
    J Crit Care; 2012 Jun; 27(3):250-4. PubMed ID: 22226424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
    Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J;
    Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use and limitations of unfractionated heparin.
    Krishnaswamy A; Lincoff AM; Cannon CP
    Crit Pathw Cardiol; 2010 Mar; 9(1):35-40. PubMed ID: 20215909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
    Kearon C; Ginsberg JS; Julian JA; Douketis J; Solymoss S; Ockelford P; Jackson S; Turpie AG; MacKinnon B; Hirsh J; Gent M;
    JAMA; 2006 Aug; 296(8):935-42. PubMed ID: 16926353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis].
    Zhai ZG; Wang C; Liu YM; Qin ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):221-6. PubMed ID: 15266820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis.
    Siragusa S; Cosmi B; Piovella F; Hirsh J; Ginsberg JS
    Am J Med; 1996 Mar; 100(3):269-77. PubMed ID: 8629671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN; Couturaud F
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged activated partial thromboplastin time in thromboprophylaxis with unfractionated heparin in patients undergoing cesarean section.
    Matsubara S; Usui R; Ohkuchi A; Okuno S; Izumi A; Watanabe T; Seo N; Suzuki M
    J Obstet Gynaecol Res; 2010 Feb; 36(1):58-63. PubMed ID: 20178528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous unfractionated heparin for treatment of venous thromboembolism in end-stage renal disease.
    Metzger NL; Chesson MM
    Ann Pharmacother; 2010 Dec; 44(12):2023-7. PubMed ID: 21098749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the standard pediatric unfractionated heparin dosing protocol.
    Al Obary EE; Al-Jazairi AS; Zaghloul IM; Saleh MM; Al Musa AS; Al-Halees Z
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):153-9. PubMed ID: 22499962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New anticoagulants in the treatment of VTE.
    Le Gal G; Mottier D
    Semin Respir Crit Care Med; 2012 Apr; 33(2):191-8. PubMed ID: 22648492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.